Phase 2 Study of Telomelysin (OBP-301) in Combination With Pembrolizumab in Esophagogastric Adenocarcinoma

Name: Phase 2 Study of Telomelysin (OBP-301) in Combination With Pembrolizumab in Esophagogastric Adenocarcinoma
License: Public Domain

Weill Medical College of Cornell University

ClinicalTrials.gov · Datasets · License: Public Domain

esophagogastric adenocarcinoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 426785
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.